These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
8. A gain-of-function mutation in zinc cluster transcription factor Rob1 drives Candida albicans adaptive growth in the cystic fibrosis lung environment. Gnaien M; Maufrais C; Rebai Y; Kallel A; Ma L; Hamouda S; Khalsi F; Meftah K; Smaoui H; Khemiri M; Hadj Fredj S; Bachellier-Bassi S; Najjar I; Messaoud T; Boussetta K; Kallel K; Mardassi H; d'Enfert C; Bougnoux ME; Znaidi S PLoS Pathog; 2024 Apr; 20(4):e1012154. PubMed ID: 38603707 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of Candida species and bacteria in patients with cystic fibrosis. Haiko J; Saeedi B; Bagger G; Karpati F; Özenci V Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1071-1077. PubMed ID: 30739228 [TBL] [Abstract][Full Text] [Related]
10. Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy. Aiyer A; Manoharan A; Paino D; Farrell J; Whiteley GS; Kriel FH; Glasbey TO; Manos J; Das T Int J Antimicrob Agents; 2021 Aug; 58(2):106372. PubMed ID: 34116184 [TBL] [Abstract][Full Text] [Related]
11. Biofilm growth and IL-8 & TNF-α-inducing properties of Candida albicans in the presence of oral gram-positive and gram-negative bacteria. Bhardwaj RG; Ellepolla A; Drobiova H; Karched M BMC Microbiol; 2020 Jun; 20(1):156. PubMed ID: 32527216 [TBL] [Abstract][Full Text] [Related]
13. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180 [TBL] [Abstract][Full Text] [Related]
15. [Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis]. Akışoğlu Ö; Engin D; Sarıçam S; Müştak HK; Şener B; Hasçelik G Mikrobiyol Bul; 2019 Jan; 53(1):22-36. PubMed ID: 30683036 [TBL] [Abstract][Full Text] [Related]
16. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Kobayashi H Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598 [TBL] [Abstract][Full Text] [Related]
17. Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions. Lopes SP; Azevedo NF; Pereira MO Biomed Res Int; 2014; 2014():678301. PubMed ID: 24868541 [TBL] [Abstract][Full Text] [Related]